These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1618 related articles for article (PubMed ID: 33554505)

  • 1. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
    Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
    Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
    Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
    Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?
    Lugito NPH
    Curr Res Transl Med; 2021 May; 69(2):103289. PubMed ID: 33845428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
    Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
    J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza.
    Li Z; He L; Li S; He W; Zha C; Ou W; Hou Q; Wang W; Sun X; Liang H
    Influenza Other Respir Viruses; 2019 Mar; 13(2):184-190. PubMed ID: 30443990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.
    Heer RS; Mandal AK; Kho J; Szawarski P; Csabi P; Grenshaw D; Walker IA; Missouris CG
    Ann Clin Biochem; 2021 Sep; 58(5):520-527. PubMed ID: 34018843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of serum procalcitonin and hypersensitive C-reactive protein levels in patients with acute cerebral infarction complicated with infection].
    Wang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):962-966. PubMed ID: 31537220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of Procalcitonin, lactate, white blood cell count and neutrophil-lymphocyte count ratio to predict blood stream infection. Analysis of a large database.
    Marik PE; Stephenson E
    J Crit Care; 2020 Dec; 60():135-139. PubMed ID: 32799183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
    Galli F; Bindo F; Motos A; Fernández-Barat L; Barbeta E; Gabarrús A; Ceccato A; Bermejo-Martin JF; Ferrer R; Riera J; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Menéndez R; Gonzalez J; Misuraca S; Palomeque A; Amaya-Villar R; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Lopez Lago A; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego Curto E; García-Garmendia JL; Gómez JM; Huerta A; Jorge García RN; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; Lopez Messa J; M Albaiceta G; Nieto MT; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Roche-Campo F; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Boado MV; Rodríguez A; Antonelli M; Blasi F; Barbé F; Torres A;
    Intensive Care Med; 2023 Aug; 49(8):934-945. PubMed ID: 37507573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.
    Milcent K; Faesch S; Gras-Le Guen C; Dubos F; Poulalhon C; Badier I; Marc E; Laguille C; de Pontual L; Mosca A; Nissack G; Biscardi S; Le Hors H; Louillet F; Dumitrescu AM; Babe P; Vauloup-Fellous C; Bouyer J; Gajdos V
    JAMA Pediatr; 2016 Jan; 170(1):62-9. PubMed ID: 26595253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
    Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
    BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using random forest and biomarkers for differentiating COVID-19 and Mycoplasma pneumoniae infections.
    Zhou X; Zhang J; Deng XM; Fu FM; Wang JM; Zhang ZY; Zhang XQ; Luo YX; Zhang SY
    Sci Rep; 2024 Sep; 14(1):22673. PubMed ID: 39349769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections.
    Duan S; Gu X; Fan G; Zhou F; Zhu G; Cao B
    BMC Pulm Med; 2021 Sep; 21(1):308. PubMed ID: 34583675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients.
    Wang RR; He M; Kang Y
    J Clin Lab Anal; 2021 Jun; 35(6):e23805. PubMed ID: 34032326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Serum Procalcitonin Concentrations in Patients With Hemorrhagic Fever With Renal Syndrome Caused by Hantaan Virus.
    Fan X; Deng H; Sang J; Li N; Zhang X; Han Q; Liu Z
    Front Cell Infect Microbiol; 2018; 8():129. PubMed ID: 29868489
    [No Abstract]   [Full Text] [Related]  

  • 17. Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19.
    Ahmed S; Ahmed ZA; Rashid NH; Mansoor M; Siddiqui I; Jafri L
    Malays J Pathol; 2021 Dec; 43(3):375-380. PubMed ID: 34958058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
    Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.